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Available online 15 December 2014Interleukin (IL)-21 is crucial for the regulation of lymphocytes and is implicated in autoimmune
and other diseases. The relevance of being able to measure human IL-21 prompted us to develop
ELISA and ELISpot assays for analysis of IL-21 levels and IL-21-producing cells, respectively.
Monoclonal antibodies (mAbs) to IL-21weremade and ELISA and ELISpot assays were developed.
The selected detection mAb also neutralized IL-21-mediated activation of human cells. Peripheral
blood mononuclear cells (PBMCs) from healthy donors (n = 24) were stimulated polyclonally
(phytohemagglutinin; PHA) or with antigen (Candida albicans extract and tetanus toxoid). Using
ELISpot, high numbers of IL-21-producing cells were detected after PHA activation; lower but
positive responses to antigenwere seen in approximately 50% of the donors. In contrast, the ELISA
detected IL-21 in supernatants from PHA-activated cells but not from antigen-stimulated cells.
When analyzing IL-17A in parallel, PHA and antigens induced detectable responses in ELISpot as
well as in ELISA. Hypothesizing that the lack of detectable IL-21 levels after antigenic stimulation
was due to a combination of low frequencies of IL-21-secreting cells and consumption of IL-21 by
cellular receptors during cell culture, PBMCs (n = 18) were stimulated in the presence of the
neutralizing detection mAb. When preventing IL-21 from interacting with its receptor, increased
IL-21 levels were found by ELISA after PHA activation and IL-21 could also be measured after
antigen stimulation. ELISpot results were unaffected by the addition of the neutralizing mAb. In
conclusion, IL-21 secreted by low frequencies of antigen-specific ex vivo-stimulated PBMC can be
difficult to detect by ELISA but prevention of IL-21 interaction with its receptor leads to detectable
IL-21 levels. In ELISpot,where the cytokine is captured bymAbs on a solid phase immediately upon
secretion, blocking the receptor interaction does not affect the detection of IL-21-secreting cells.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Th171. Introduction
Interleukin (IL)-21 is an important regulatory cytokinewith
impact on both innate and adaptive immune cells. It is mainlyK, human embryonic
BMC, peripheral blood
hytohemagglutinin; rh,
cell; TT, tetanus toxoid.
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cecilia@mabtech.com
abtech.com (B. Zuber),
.V. This is an open access articproduced by activated CD4+ T cells, follicular T-helper cells
(Th) and natural killer T cells (Leonard et al., 2008) and targets
a number of IL-21 receptor-expressing cells, primarily B, T and
NK cells but also macrophages and dendritic cells (Spolski and
Leonard, 2008). The IL-21 receptor is comprised of an IL-21-
specific receptor chain (IL-21Rα) and the common gamma
chain (CD132) that is shared by the receptors for IL-2, IL-4, IL-7,
IL-9 and IL-15 (Spolski and Leonard, 2008). Important biolog-
ical effects of IL-21 include the induction of T-cell differentia-
tion into Th17 cells that produce IL-17A and also contribute to
IL-21 production (Korn et al., 2007), enhanced proliferation
and cytotoxic activity of CD8+ T cells (Liu et al., 2007),le under the CC BY-NC-ND license
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activation ofmonocytes (Vallieres andGirard, 2013). In concert
with other cytokines and signaling molecules, IL-21 also
regulates the development and activation of B cells into Ig-
secreting cells (Ozaki et al., 2004; Moens and Tangye, 2014).
Due to its importance as a regulatory cytokine, an aberrant
production of IL-21 may also have pathogenic consequences,
and studies in mice have demonstrated its potential involve-
ment in a variety of immune-related conditions including
inflammatory disease and autoimmunity (Ozaki et al., 2004;
Vinuesa et al., 2005; Vogelzang et al., 2014). In humans, T cells
producing IL-21 have been shown to be increased in patients
with systemic lupus erythematosus, coinciding with a similar
increase in IL-17A producing T cells (Dolff et al., 2011), in
rheumatoid arthritis (Ma et al., 2012) and in celiac disease (van
Leeuwen et al., 2013). Furthermore, there is evidence for IL-21
serving as a potential tumorigenic factor in certain lymphomas
(Lamprecht et al., 2008; van der Fits et al., 2012) but, IL-21 also
has the capacity to induce apoptosis in other lymphomas
(Akamatsu et al., 2007; Gelebart et al., 2009).
Considering the central role of IL-21, accurate tools for its
measurement are vital. Two widely used techniques for
measuring secreted cytokines are ELISA and ELISpot. These are
similar in principle but measure different aspects of cytokine
secretion with ELISA providing information about the levels in
e.g. cell supernatants or plasma samples and ELISpot enumer-
ating the frequencies of cytokine-secreting cells.
In the current study, we developed monoclonal antibodies
(mAbs) to human IL-21 and evaluated their functionality in
ELISA and ELISpot using peripheral blood mononuclear cells
(PBMCs) stimulated polyclonally orwith specific antigen. In the
process, we found that IL-21 responses to the antigens tetanus
toxoid (TT) and Candida albicans extract (CA) were readily
detected by ELISpot but not by ELISA. A strategy to incubate
PBMC in the presence of the detection mAb, identified as a
neutralizing antibody, resulted in improved detection of IL-21
by ELISA and enabled recognition also of antigen-specific
responses.
2. Materials and methods
2.1. Generation of mAbs to human IL-21 for use in capture ELISA
and ELISpot
MAbs were made using methods described previously
(Zuber et al., 2005). Briefly, hybridomas were generated using
cells from BALB/c mice immunized with recombinant human
(rh)IL-21 (Peprotech, Rockville Hill, NJ, USA). Mice were
treated according to the guidelines of the Swedish Ethical
Committee for Animal Protection. rhIL-21-reactive hybridomas
were identified by ELISA; selected hybridomas were subcloned
andmAbs were produced and purified on Protein G columns. A
quantity of each mAb was biotinylated to allow its use as
detection reagent. Finally, themAbs were tested in capture and
detection combinations to identify the optimal pair ofmAbs for
ELISA and ELISpot.
2.2. Preparation of human PBMC
PBMCs were isolated from buffy coats of anonymous
healthy blood donors from Karolinska University Hospital(Solna, Sweden) and frozen as described (Makitalo et al.,
2002). Before use, PBMCs were thawed at 37 °C, and washed
in culturemedium(RPMI-1640with 10% fetal calf serum, 2mM
L-glutamine, 100 IU/ml penicillin, 100 μg/ml streptomycin and
1 mM HEPES; Life Technologies, Glasgow, UK). After being
rested for 1 h in a 37 °C incubator with 5% CO2, PBMCs were
resuspended and aggregated cell debris was allowed to
sediment for 1 min. Following that, cells in suspension were
moved to a new vial and PBMCs were counted using a Guava
EasyCyte mini (Millipore, Billerica, MA, USA).
2.3. MAb blocking of IL-21 receptor interaction with transfected
HEK cells
Plasmids were produced by Genscript (Pisctaway, NJ, USA).
Synthesized genes encoding, IL-21 receptor (Uniprot Q9HBE5),
common gamma chain (Uniprot P31785), Janus kinase 3
(Uniprot P52333) and signal transducer and activator of
transcription 3 (Uniprot P40763) were cloned into plasmid
pcDNA 3.1/Zeo (Life Technologies/Invitrogen, Carlsbad, CA,
USA). pGL4.52-SEAP-SIE-RE-Hygro STAT3 reporter plasmid
was made by modifying plasmid pGL4.52-luc2P-STAT5-RE-
Hygro (Promega, Madison, WI, USA); a secreted alkaline
phosphatase gene from the pSEAP2 vector U89937 (Clontech,
Mountain View, CA, USA) was used to replace the luc2P gene
and the STAT5 response element was replaced with the STAT3
(SIE) response element from pGL4.47-luc2P-SIE-RE-Hygro
(Promega). IL-21 responsive human embryonic kidney (HEK)
293T/17 cells (LGC AB, Borås, Sweden) were made by co-
transfection with the above (five) plasmids. HEK 293T/17 cells
were selected based on high transfectability, the cells constitu-
tively express the simian virus 40 (SV40) large T antigen that
permits episomal replication of plasmid pcDNA 3.1/Zeo, which
contains a SV40 ori. Cell media and transfection reagents were
from Life Technologies. Cells were seeded in 6-well tissue
culture plates at 1 × 106 cells/well in 2 ml DMEMmediumwith
10% fetal calf serum and cultured overnight at 37 °C with 5%
CO2. Cells were transfected with plasmids (0.5 μg/plasmid)
together with 5 μl Lipofectamine 2000 in Opti-MEM
+ GlutaMAX according to the manufacturer's instructions.
After 20h, cellsweredetachedusing0.05% trypsin/EDTA,washed,
resuspended in AIM-Vmedium and counted in a Guava EasyCyte
mini. The IL-21 mAbs and an anti-bacterial negative control
mAb (Ly128) were preincubated with rhIL-21 (Peprotech) in
100 μl AIM-V for 1 h at 37 °C and added to 2.5 × 105 transfected
cells in 100 μl AIM-V in a 96-well cell culture plate with a final IL-
21 concentration of 10 ng/ml. After 20 h of incubation at 37 °C
with 5% CO2, 20 μl cell supernatant was mixed with 200 μl pNPP
substrate (Mabtech, Nacka Strand, Sweden) in Maxisorp 96-well
plates (Nunc, Roskilde, Denmark) and absorbance at 405 nmwas
measured.
2.4. MAb blocking of rhIL-21 receptor interaction with PBMC
MAbs and rhIL-21 were preincubated as above and incubat-
ed in 200 μl cell culture medium with 3 × 105 PBMC/well in a
cell culture plate at 37 °C with 5% CO2 for 4 days. One hundred
microliters from each well was added to human IgG ELISpot
plates and incubated for 6 h. The number of IgG-producing B
cells was enumerated in a human IgG ELISpot (Mabtech)
following the manufacturer's instructions.
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Fig. 1. Functionality ofmAbs to human IL-21 in ELISA and ELISpot. A) FourmAbs
(MT3–MT6) reactive with rhIL-21 were tested in all possible capture and
detection mAb combinations in ELISA using rhIL-21 as analyte. The detection
mAbs were biotinylated (b). Non-functional combinations are shown as All
other. B) The combination of capturemAbMT6 and biotinylated detectionmAb
MT3was evaluated in ELISpot. Shown are images obtainedwith 5 × 105 PBMC/
well (from one donor) incubated without stimuli or with tetanus toxoid (TT),
Candida albicans extract (CA) or phytohemagglutinin (PHA).
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neutralizing mAb
PBMCs were mixed with 5 μg/ml of phytohemagglutinin
(PHA;Oxoid AB,Malmö, Sweden), 13 μg/ml of CA (Greer, Lenoir,
NC, USA) or 7.2 LF/ml of TT (Statens Serum Institut, Copenhagen,
Denmark) ormedium only. Cell concentrationswere adjusted to
5×106 cells/ml. In someexperiments, the biotinylateddetection
mAb MT3 was added to the cultures at 1 μg/ml. PBMCs were
incubated at 37 °C with 5% CO2 for 40 h in 96-well cell culture
plates (TPP, Nordic Biolabs, Täby, Sweden) for preparation of cell
supernatants for ELISA analysis (200 μl/well; 5 × 106 cells/ml).
Alternatively, PBMCs were incubated for 40 h directly in ELISpot
wells (100 μl/well; 5 × 106 cells/ml).
2.6. ELISpot
The IL-21 ELISpot was performed essentially as described
(Minang et al., 2008). Briefly, PVDF plates (Millipore) were EtOH
treated and coated with mAb MT6 (10 μg/ml) at +4 °C. PBMCs
were incubated with or without stimuli at 37 °C and 5% CO2 for
40 h. The plates were then incubated with detection mAb MT3-
biotin (1 μg/ml) for 2 h at RT, followed by streptavidin-
horseradish peroxidase conjugate for 1 h at RT (Mabtech) and
developed with precipitating TMB substrate for 15 min
(Mabtech). ELISpot assays were set up in triplicates. A human
IL-17A ELISpot kit (Mabtech) was run in parallel using the same
protocol. Spots were counted using an ELISpot reader (iSpot
Spectrum, AID, Strassberg, Germany). PBMCs responding to
antigen with N3× more spots and an increase of N10 spots
compared to those of the unstimulated PBMCs from the same
donor were considered positive.
2.7. ELISA
Maxisorp 96-well plates were coated for 16 h at 4 °C with
2 μg/ml capture mAb MT6 in 100 μl phosphate-buffered saline
(PBS). Other assay steps were performed at RT using 100 μl/well
except for washes between assay steps where 200 μl/well of
PBS/0.1% Tween 20 was used. Coated wells were blocked for 1 h
with incubation buffer (PBS with 0.05% Tween 20 and 0.1%
bovine serum albumin). After incubation of rhIL-21 or superna-
tant for 2 h, detection mAb MT3-biotin at 1 μg/ml in incubation
buffer was incubated for 1 h followed by streptavidin horserad-
ish peroxidase conjugate in incubation buffer for 1 h. The assay
was developed with soluble TMB substrate (Mabtech) and
stopped with 1 M H2SO4 and absorbance at 450 nm was
measured. A human IL-17A ELISA kit (Mabtech) was run in
parallel using the same protocol. Both ELISAs yielded a lowest
detection limit below 10 pg/ml (lowest cytokine concentration
yielding an absorbance value higher than that of the mean
background + 3 SD in repeated tests) but the limit was set to
10 pg/ml due to low OD values (b0.1) at the lowest standard
concentrations. PBMCs responding to antigen with N2× higher
levels and an increase of N10 pg/ml compared to those of the
unstimulated PBMCs from the same donor were scored positive.
2.8. Statistics
The correlation between antigen-specific cytokine responses
analyzed in different assays was assessed using Spearman'srank order correlation coefficient rs. Values obtained with
unstimulated cells were subtracted from those obtained with
antigen-stimulated cells.
3. Results and discussion
The aim of this study was to develop effective and sensitive
means of measuring human IL-21 secretion both in cell culture
supernatants by ELISA and at the single cell level by ELISpot.
Four newmAbswith high reactivity with rhIL-21were assessed
for functionality as capture/detection pairs in ELISA. The
combination of mAb MT6 for capture and mAb MT3-biotin for
detection yielded a lowest detection limit of rhIL-21 below
10 pg/ml in ELISAwhich is comparable to other highly sensitive
cytokine ELISAs utilizing the same amplification system (biotin–
streptavidin) and enzymatic detection with colorimetric sub-
strates (Fig. 1A). After confirming reactivity of the mAb pair
with native IL-21 and functionality in theELISpot assay (Fig. 1B),
this combination was selected for subsequent experiments.
MAb MT5 was fully comparable to MT3 as detection mAb.
The mAbs were also tested for their capacity to neutralize
IL-21 using transfected HEK cells responsive to IL-21 (Fig. 2A).
MAb MT3, the selected detection mAb, efficiently inhibited IL-
21-mediated activation (MT5 yielded identical results and is
not shown in the figure) andMT4 had a weak inhibitory effect.
In contrast, MT6 amplified the IL-21-mediated activation. We
could not find other anti-cytokine mAbs with such amplifying
effects in vitro in the literature. The impact of themAbs to IL-21
was therefore further analyzed with primary human PBMC
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Fig. 2. Neutralizing capacity of mAbs to IL-21. A) Neutralization assay using HEK cells transfected with plasmids encoding the IL-21 activation pathway and secreted
alkaline phosphatase as a reporter. The cells were stimulated with rhIL-21 with or without serial dilutions of anti-IL-21 mAbs MT3, MT4, and MT6 and an isotype/
subclass matched control mAb (all mAbs are IgG1 κ). Following incubation for 20 h, enzyme activity in supernatants was measured. Data shown is the mean of two
experiments. B)Neutralization assay using humanPBMCs incubated for 4 dayswith rhIL-21 in the presence ofmAbs followedby thedetection of IgG-secreting B cells by
ELISpot. The data shown is themean of results from two PBMCdonors. rhIL-21-induced B-cell responses in the absence of mAbswere 75 and 140 spots/200,000 PBMCs
and spontaneous B cells secreting IgG without rhIL-21 yielded b5 spots/200,000 PBMCs. PBMCs from an additional 10 donors yielded similar results when IgG levels
were measured by ELISA after incubation with rhIL-21 +/−mAbs (not shown).
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the fact that IL-21 activates memory B cells to become plasma
cells (Ozaki et al., 2004; Ettinger et al., 2005), PBMCs were
incubated with IL-21 and mAbs and the number of IgG-
secreting B cells were enumerated (Fig. 2B). MT3 (and MT5)
again displayed a neutralizing effect whereas MT4 had no
effect. MT6, however, displayed a reversed effect, compared to
its effect on HEK cells, and neutralized the IL-21 activation of
PBMC as efficiently asMT3. Similar resultswere obtainedwhen
IgG levels rather than IgG-secreting cells were measured
(data not shown). A possible explanation for the amplifying
effect of MT6 alone on IL-21-activated HEK cells could be
that IL-21 signaling occurs via antibody cross-linking and
homodimerization of one of the chains in the IL-21 receptor,
something that may be facilitated by its likely high expression
in the transfected cells. Stimulation via receptor aggregation
can be induced naturally via dimeric ligands or artificially via
anti-receptor antibodies; in the case of the IL-4 receptor,
sharing the common gamma chain with the IL-21 receptor,
antibody-mediated homodimerization of the IL-4Rα chain was
shown to lead to intracellular signaling (Kammer et al., 1996).
In the current case, homodimerizationmight be induced by the
MT6 antibody binding divalently to an epitope of IL-21 that is
not involved in its interaction with the signaling chain. The fact
that amplificationwas optimal at a certain ratio of MT6:rhIL-21
but decreased at higher concentrations where the antibody
could be expected to bindmonovalently (Fig. 2A), supports the
hypothesis of MT6-induced homodimerization.
The IL-21 capture assays developedwere used to analyze IL-
21 secretion by PBMC from healthy subjects (n = 24),
stimulated polyclonally with PHA or with antigen (TT and
CA). As shown in Fig. 3A, the ELISpot detected PHA-induced IL-
21-secreting cells in PBMCs from all donors and lower but
positive responses to TT and CA in 50% and 58% of the donors,
respectively. While the response to PHA was also readily
measured in 23/24 donors in the ELISA, this assay completely
failed to detect antigen-specific responses (Fig. 3B).
IL-17A analysis performed in parallel yielded comparable
results as for IL-21 in the ELISpot with high responses to PHAand lower but positive responses to specific antigen; 38% of the
donors responded to TT and 71% to CA (Fig. 3C). The ELISpot
results for the two cytokines were also found to be positively
correlated with regard to the antigen-specific responses (rs =
0.78 for TT and 0.70 for CA; p b 0.0001). Th17 cells are involved
in the immune response to the fungus C. albicans (Jager and
Kuchroo, 2010) and simultaneous production of both IL-17A
and IL-21 by this cell type may explain the correlated response
to CA antigen. A previous study has shown IL-17A responses to
TT by PBMC at the mRNA level but failed to detect secreted
protein by ELISA (Lenarczyk et al., 2000). The correlation
between IL-17A and IL-21 responses to TT seen herein suggests
the involvement Th17 cells also in the response to TT
vaccination.
In contrast to IL-21, IL-17A responses to TT and CAwere also
observed in ELISA with similar numbers of responders as seen
in the ELISpot; 42% responding to TT and 75% to CA (Fig. 3D).
The antigen-specific IL-17A responsesmeasured by ELISpot and
ELISA (Fig. 3C & D) were positively correlated (rs = 0.82 for TT
and 0.74 for CA, p b 0.0001).
In view of the similar ELISpot results for IL-21 and IL-17A,
the distinct discrepancy in the detection of these two cytokines
in ELISA was somewhat surprising. An important difference
between ELISpot and ELISA is that, in the ELISpot, the cytokine
is captured by the coated mAbs immediately upon secretion
whereas ELISA measures the net amount of cytokine in a
culture supernatant after potential binding to soluble or cellular
receptors. Such receptor consumption has previously been
demonstrated for IL-4 which, similar to the findings here with
IL-21, is notoriously difficult to detect by ELISA after antigen-
specific ex vivo stimulation of PBMC, while more easily
detected in ELISpot (Minang et al., 2008). This has been
explained by an up-regulation of IL-4 receptors on various
cells during stimulation (Renz et al., 1991; Carter and Swain,
1997) followed by an increased receptor consumption of
secreted IL-4. In support of this, the addition of IL-4 receptor-
blocking antibodies during antigenic stimulation has been
shown to result in increased levels of IL-4 in cell supernatants,
thus demonstrating that even low frequencies of T cells can
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Fig. 3. ELISA and ELISpot analyses of IL-17A and IL-21 secretion by ex vivo-stimulated PBMC. PBMCs from24healthy subjectswere incubated for 40 h in IL-21 (A) and IL-
17A (C) ELISpot wells or in cell culture plates for subsequent analysis of supernatants by IL-21 (B) and IL-17A (D) ELISA. Unstimulated, antigen-stimulated (Candida
albicans, CA; tetanus toxoid, TT) and phytohemagglutinin (PHA)-stimulated cells were used at 5 × 106 PBMCs/ml. Spots/well exceeding 1000 spots/well were set to
N1000 spots/well. IL-21 levels in ELISA exceeding 1000 pg/ml are shown as N1000 pg/ml. The lowest detection limit of the ELISAs was set to 10 pg/ml. Each symbol
represents PBMC from one individual.
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consumption is prevented (Ewen and Baca-Estrada, 2001).
To test whether receptor consumption could be a reason for
the discrepancy between the IL-21 ELISA and ELISpot results, the
experiments were repeated and PBMCs (n = 18) were
incubated as before or in the presence of the anti-IL-21
neutralizing mAb MT3. The mAb was biotinylated since non-
labeled MT3 otherwise could interfere with the subsequent
ELISA detection. As seen in Fig. 4A and B, results from PBMC
incubated without the neutralizing mAb were comparable to
those from the initial results (Fig. 3A & B) i.e. antigen-specific
responses were observed in ELISpot but not in ELISA. However,
the addition of mAb MT3 to the cell culture had a prominent
effect on ELISA results (Fig. 4D) increasing the average PHA-
induced levels of IL-21 nearly fourfold (from 890 pg/ml to
3400 pg/ml) and, more important, made previously non-
detectable antigen-specific responses measurable. The addition
of MT3 to unstimulated cells did not enhance IL-21 levels
showing that the mAb prevents the loss of IL-21 rather than
elevating the levels throughnon-specific induction. Although the
antigen-induced IL-21 levels were in all cases low (b50 pg/ml)
and failed to detect that all donors scored as positive in the
ELISpot, IL-21 levels detected by ELISA in supernatants made in
the presence of the neutralizing mAb correlated with ELISpot
(rs = 0.70, p = 0.0006 for TT and 0.61, p = 0.074 for CA).
In ELISpot, the addition of blocking mAb to IL-21 had no
effect on the response and cells incubated with or without
blockingmAbdisplayed similar numbers of spots in response to
antigens (Fig. 4A andC) andwere strongly correlated (rs=0.95for TT and 0.93 for CA, p b 0.0001). The absence of any effect of
the mAb in ELISpot resembles the use of an IL-4 receptor-
blocking mAb that increased IL-4 levels but had no impact on
ELISpot results (Ewen and Baca-Estrada, 2001).
In conclusion, although higher levels of IL-21, such as those
induced by polyclonally activated PBMC, can be readily
measured by IL-21 ELISA, IL-21 secreted by lower frequencies
of antigen-specific cells is more difficult to measure. The use of
IL-21 ELISA thus involves a risk of drawing incorrect conclu-
sions with regard to the involvement of IL-21 in various
immune responses or diseases. Similar to IL-4, IL-21 may be
more reliably analyzed by ELISpot. Cytokine binding to
receptors during cell culture may explain the loss of these
cytokines in cell supernatants whereas other cytokines, both
Th1 and Th2 cytokines, often can be found using both ELISA and
ELISpot when analyzing antigen-specific ex vivo-stimulated
PBMC.Acknowledgment
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